China's National Medical Products Administration Archives - PharmaLive

Chinese herbal supplement joins list of disavowed COVID-19 therapies

Approvals (China), China Food and Drug Administration, China National Medical Products Administration (NMPA), China's National Medical Products Administration, COVID-19 Therapeutic, COVID-19 Therapies, Forbes, Global Times, Herbal Medications, Herbal Remedies, National Healthcare Security Administration (NHSA) (China), Studies, The China Food and Drug Administration

The Chinese government halted the recommendation of an herbal supplement used as a traditional Chinese treatment for mild cases of COVID-19.

April 18, 2022/by BioSpace

China approves Sinovac Biotech COVID-19 vaccine for general public use

Brazil, China, China's National Medical Products Administration, Clinical Trials, COVAX Facility, COVID-19 Vaccines, Efficacy Data, R&D, Sinovac

Sinovac Biotech’s Covid-19 vaccine was approved for use by the general public by China’s medical products regulator.

February 6, 2021/by Reuters Health